Prices delayed by at least 15 minutes | Prices updated on 30 May 2025, 18.08 BST | Print
Immupharma PLC (IMM)
ORD 1PNot yet a customer?
Low cost dealing from £1.50Choose from our range of SIPP, ISA and Dealing accounts
Find out moreThis share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPPand can be used with Dividend reinvestment
Income statement
| 2020 | 2021 | 2022 | 2023 | 2024 | Trend | |
|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | |
| Pretax income | -7 | -9 | -4 | -3 | -3 | |
| Net income | -7 | -8 | -4 | -3 | -2 | |
| Diluted EPS | -0.03 | -0.03 | -0.01 | -0.01 | -0.01 | |
| Normalized diluted EPS | -0.03 | -0.02 | -0.01 | -0.01 | -0.01 |
Balance sheet
| 2020 | 2021 | 2022 | 2023 | 2024 | Trend | |
|---|---|---|---|---|---|---|
| Total assets | 11 | 6 | 4 | 3 | 1 | |
| Total liabilities | 1 | 2 | 1 | 2 | 2 | |
| Total debt | 1 | 0 | 0 | - | - | |
| Total equity | 10 | 4 | 3 | 1 | -1 | |
| Cash and cash equivalents | 6 | 2 | 1 | 0 | 0 |
Cash flow
| 2020 | 2021 | 2022 | 2023 | 2024 | Trend | |
|---|---|---|---|---|---|---|
| Operating | -4 | -5 | -3 | -2 | -2 | |
| Investing | -1 | -0 | -0 | 0 | 1 | |
| Financing | 8 | 1 | 2 | 1 | 1 | |
| Free cash flow | 8 | 1 | 2 | 1 | 1 |
Key ratios
| Company | ||
|---|---|---|
| PER (E) | Ratio | - |
| Dividend yield (E) | Percentage | 0.00 |
| Price earning growth (E) | Ratio | - |
| Return on equity | Percentage | -967.41 |
| Operating margin | Percentage | - |
| Earning per share growth (E) | Percentage | -0.01 |
| Enterprise value/earnings before interest, taxes, depreciation and amortization | Multiple | - |
| Price to tangible book value | Multiple | - |
| Price/Cash flow | Multiple | - |
| Price/Sales | Multiple | - |
GBP in millions except per share data.
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2025 AJ Bell. All rights reserved.